- Daily tablet capacity is rising to 300,000 units, while capsule capacity will reach 500,000 units.
- The Sonipat facility will also produce 5,000 liters of syrups and one metric ton of powders per day.
Conch Lifescience, a Sonipat, Haryana-based third-party nutraceutical manufacturer, said Nov. 6 that it is upgrading its Rai Industrial Area plant to increase output across tablets, capsules, syrups and powders. The company supplies private-label, white-label and custom formulations for supplement brands.
Once the upgrade is complete, tablet capacity will triple from about 100,000 to 300,000 units per day. Capsule capacity will rise 2.5-fold from 200,000 to 500,000 units, while syrup output will increase from 2,000 to 5,000 liters. Powder production will double from 500 kg to one metric ton daily.
The expansion supports a portfolio of more than 150 pre-approved formulations and production services that extend from formulation and ingredient selection through packaging. Conch says the plant can handle low minimum orders for startups as well as larger runs for established brands, giving sponsors several routes from stock formulations to custom products. The company says it works with more than 500 partners and manages more than 300 SKUs across the Indian supplement market.
The manufacturer established its Sonipat unit in 2015 and launched third-party manufacturing services in 2018. It identifies the facility as ISO 9001:2015 certified and compliant with ISO 22000:2018 and WHO-GMP requirements. Conch did not disclose the upgrade’s capital cost or completion date. Founder Vivek Kumar said:
“Our objective at Conch Lifescience is to make these capabilities accessible to businesses at different stages of growth.”
Vivek Kumar, founder, Conch Lifescience
